• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血清癌胚抗原倍增时间及降钙素水平在甲状腺髓样癌中的预后价值]

[Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].

作者信息

Miyauchi A, Onishi T, Matsuzuka F, Hirai K, Kuma K, Takai S, Nakamoto K, Nakamura K, Nanjo S, Maeda M

出版信息

Gan No Rinsho. 1986 Oct;32(12):1519-24.

PMID:3783976
Abstract

Fifteen patients operated on for medullary thyroid carcinoma with elevated postoperative serum calcitonin (CT) levels underwent serial measurements of serum CT and carcinoembryonic antigen (CEA) levels. Both CT and CEA levels showed an exponential increase in 12 patients and a slight decrease in three. CEA levels manifested less fluctuation than CT levels. The doubling time of these tumor marker levels calculated from the regression line in each patient showed a strong correlation with three-year survival, recurrence within five years, and the time interval between surgery and recurrence of the tumor, allowing quantitative prediction of the prognosis. However, the doubling time of CEA was longer than that of CT in most patients.

摘要

15例接受手术治疗的甲状腺髓样癌患者术后血清降钙素(CT)水平升高,对其进行了血清CT和癌胚抗原(CEA)水平的系列测量。CT和CEA水平在12例患者中呈指数上升,3例呈轻微下降。CEA水平的波动小于CT水平。根据每位患者的回归线计算出的这些肿瘤标志物水平的倍增时间与三年生存率、五年内复发情况以及手术与肿瘤复发之间的时间间隔密切相关,从而能够对预后进行定量预测。然而,在大多数患者中,CEA的倍增时间长于CT的倍增时间。

相似文献

1
[Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].[血清癌胚抗原倍增时间及降钙素水平在甲状腺髓样癌中的预后价值]
Gan No Rinsho. 1986 Oct;32(12):1519-24.
2
Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.甲状腺髓样癌手术细胞减灭术可导致血清降钙素和癌胚抗原倍增时间增加。
Exp Clin Endocrinol Diabetes. 2012 Mar;120(3):164-8. doi: 10.1055/s-0032-1301897. Epub 2012 Feb 10.
3
[Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].[甲状腺髓样癌中的血浆肿瘤标志物(降钙素和癌胚抗原)]
Bull Cancer. 1984;71(2):133-9.
4
[Evaluation of surgical results and prediction of prognosis by analysis of serum tumor marker levels: proposal of a theory tested on patients with medullary thyroid carcinoma].通过分析血清肿瘤标志物水平评估手术结果及预测预后:对甲状腺髓样癌患者验证的一种理论建议
Gan No Rinsho. 1988 May;34(6):739-43.
5
[Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].[通过血清降钙素水平分析评估甲状腺髓样癌的外科治疗]
Nihon Geka Gakkai Zasshi. 1987 Jan;88(1):102-8.
6
[Use of tumor markers in monitoring thyroid carcinoma].[肿瘤标志物在甲状腺癌监测中的应用]
Chir Ital. 1987 Feb;39(1):87-95.
7
Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.甲状腺髓样癌中降钙素与癌胚抗原水平的相关性。
Biomedicine. 1977 Mar;27(2):52-4.
8
Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis.降钙素和癌胚抗原倍增时间作为甲状腺髓样癌的预后因素:一项结构化荟萃分析。
Clin Endocrinol (Oxf). 2010 Apr;72(4):534-42. doi: 10.1111/j.1365-2265.2009.03666.x. Epub 2009 Jun 26.
9
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.甲状腺髓样癌的进展:降钙素和癌胚抗原倍增时间的评估
Eur J Endocrinol. 2008 Feb;158(2):239-46. doi: 10.1530/EJE-07-0667.
10
[Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].[血清降钙素、癌胚抗原和甲胎蛋白检测在甲状腺髓样癌复发早期诊断中的应用价值]
Wiad Lek. 2002;55(7-8):394-403.

引用本文的文献

1
The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.日本内分泌外科学会2024年修订的甲状腺肿瘤管理临床指南。
Endocr J. 2025 May 7;72(5):545-635. doi: 10.1507/endocrj.EJ24-0644. Epub 2025 Mar 8.
2
Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels.
World J Surg. 1988 Oct;12(5):610-5. doi: 10.1007/BF01655862.